Convalife Pharmaceuticals Alternatives & Competitors

12 companies similar to Convalife Pharmaceuticals — Pioneering the future of tumor disease treatment through advanced pharmaceutical...

Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...

2-10 Series A $18.50M

Biopharma Biotechnology +1

Day One Biopharmaceuticals

Cancer drug development comes of age.

190 Post-IPO Equity $687.50M

Brisbane, United States

Biopharma Biotechnology +2

Kanova

Pioneering advanced therapies in immuno-oncology and autoimmune diseases.

2-10 Series B $215.00M

Biopharma Health and Wellness +1

OncXerna Therapeutics

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...

8 Venture round $126.50M

Waltham, United States

Biopharma Biotechnology +3

Track all Convalife Pharmaceuticals competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Cage Pharma

Innovative pre-clinical biopharma advancing tumor-targeting therapies with groundbreaking...

0-1 Venture round $967.49K

Biopharma Biotechnology +1

Elevation Oncology

We are focused on discovering and developing selective cancer therapies to treat patients...

5 Acquired $232.95M

Boston, United States

Biopharma Biotechnology +3

Biodexa Pharmaceuticals PLC

Advancing Medicines for a Brighter Future

25 Post-IPO Equity $36.56M

Cardiff, United Kingdom

Biopharma Biotechnology +2

OnQuality Pharmaceuticals Ltd.

developing innovative drugs and drug delivery systems that improve the quality of life of...

7 Series A $35.00M

Shanghai, China

Biopharma Biotechnology +3

Sitka Biopharma

We're transforming chemotherapies to further benefit patients by enhancing efficacy & impr...

2-10 Venture round $5.50M

Canada

Biopharma Biotechnology +1

ONCOtracker, Inc

A leading incubator for cancer treatment innovations with a focus on the diagnosis and tre...

West Hollywood, United St...

Biopharma Pharmaceutical

Targazyme

11 Series A $60.00M

Biopharma Biotechnology +2

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

About Convalife Pharmaceuticals

Convalife Pharmaceuticals, founded in 2018, is pioneering the future of tumor disease treatment through advanced pharmaceutical research and development. Specializing in the Biopharma and Pharmaceutical industries, the company's slogan embodies its commitment to innovation. In December 2023, Convalife Pharmaceuticals s...

Business keywords

Pharmaceutical Research, Drug Development, Tumor Diseases, Cancer Treatment, Oncology, Pharmaceutical Company, Innovation, Medical Research, Clinical Trials

Frequently Asked Questions

Companies similar to Convalife Pharmaceuticals include Nirogy Therapeutics, Day One Biopharmaceuticals, Kanova, OncXerna Therapeutics , Cage Pharma. They work in Biopharma and Pharmaceutical and share Convalife Pharmaceuticals's focus on drug development, cancer treatment and oncology.

Bounce Watch lists 12 companies that share Convalife Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Convalife Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Convalife Pharmaceuticals Profile Nirogy Therapeutics Alternatives Day One Biopharmaceuticals Alternatives Kanova Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Convalife Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 17 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.